Why did Fortis Healthcare (FORTIS) stock move recently?

On 8/12/2026, Fortis Healthcare moved -6.0% — Fortis Healthcare fell with hospital stocks after a Parliamentary Standing Committee recommended benchmarking private hospital room charges against three-star hotel tariffs and introducing fixed package rates for standard procedures. This is MarketChacha's decoded reason from filings and credible news; it is education, not buy/sell advice.

Is Fortis Healthcare (FORTIS) overvalued or fairly valued?

MarketChacha shows Fortis Healthcare's valuation in context — a forward P/E of about 40.3, a price-to-book of about 7.0 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Fortis Healthcare's revenue?

Fortis Healthcare reported revenue of ₹9,128 Cr for FY2026, with net profit of ₹1,042 Cr, per official filings.

What is the share price of Fortis Healthcare (FORTIS)?

Fortis Healthcare last traded at ₹905.00 (-1.1% on the day), as of 9/4/2026 — a delayed quote shown for education, not investment advice.

Fortis Healthcare

FORTIS · NSE · Healthcare · India

Snapshot

TickerFORTIS

ExchangeNSE

SectorHealthcare

IndustryMedical Care Facilities

CountryIndia

Employees14,649

HeadquartersGurugram, India

Websitewww.fortishealthcare.com

Filings tracked8

About Fortis Healthcare

Fortis Healthcare Limited operates as a healthcare delivery service provider in India. The company services in the areas of cardiac science, nephrology, diabetology/endocrinology, foetal medicine, infectious diseases, mental health and behavioral science, oncology, orthopedics, physiotherapy and rehabilitation, rheumatology, urology, nuclear medicine, critical care, emergency and trauma, general surgery, internal medicine, neurointerventional radiology, obstetrics and gynaecology, pediatrics, pediatrics, vascular surgery, and support facilities. It also provides services in the areas of infertility medicine, dental science, endocrine surgery, geriatric medicine, liver transplant and hepatobiliary sciences, neurology, ophthalmology, pain and palliative medicine, pulmonology, thoracic surgery, gastroenterology sciences, dermatology, ENT, haematology, medical generics, neurology, organ transplant, radiology, and transfusion medicines. In addition, the company offers various spectrum integrated healthcare services ranging from clinics to quaternary care facilities and a range of ancillary services, as well as secondary, and tertiary care services. The company's healthcare verticals comprise hospitals, diagnostics, and day care specialty facilities. Fortis Healthcare Limited was incorporated in 1996 and is based in Gurugram, India.

Who owns it

Promoters35.2%
Institutions50.5%
Public & other14.3%

191 institutional holders

Ownership breakdown from public market data. Promoter pledge is not included here — that comes from exchange shareholding filings.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Net margin trend9.3% → 11.4%

Margin has expanded by about 2.1 points — the business is getting more profitable.

Growth qualityrev 13% · PAT 21%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (Yahoo Finance). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev ₹2,570 Cr · EPS 4.39

Est. earnings growth +45.4%

Next fiscal year

Rev ₹12,264 Cr · EPS 22.75

Est. earnings growth +33.7%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: Yahoo Finance

Annual

Quarterly · last 5

Revenue (FY2026)

₹9,128 Cr

Net margin

11.4%

Revenue CAGR (3y)

+13.2%

Profit CAGR (3y)

+21.0%

Net profit (FY2026)

₹1,042 Cr

Ask MarketChacha about FORTIS

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

Aug 12, 2026
Fortis Healthcare fell with hospital stocks after a Parliamentary Standing Committee recommended benchmarking private hospital room charges against three-star hotel tariffs and introducing fixed package rates for standard procedures.
source 1 ↗· confidence: high

Daily moves with the verified reason behind them. Education only — not investment advice.

Financials

Yearly

Period	Revenue	Net profit	Net margin
FY2026	₹9,128 Cr	₹1,042 Cr	11.4%
FY2025	₹7,783 Cr	₹774 Cr	9.9%
FY2024	₹6,893 Cr	₹601 Cr	8.7%
FY2023	₹6,298 Cr	₹589 Cr	9.3%

Quarterly

Period	Revenue	Net profit	Net margin
Q1 FY27	₹2,545 Cr	₹266 Cr	10.5%
Q4 FY26	₹2,365 Cr	₹266 Cr	11.2%
Q3 FY26	₹2,265 Cr	₹194 Cr	8.6%
Q2 FY26	₹2,331 Cr	₹322 Cr	13.8%
Q1 FY26	₹2,167 Cr	₹260 Cr	12.0%

Figures as reported, in ₹ (crore). Source: Yahoo Finance.

Filings & announcements

2026

Regarding Order Passed By The Hon'Ble Delhi High Court In Relation To Certain Applications Filed By Daiichi Sankyo Company, Limited Inter Alia The Company. Detailed Disclosure Is Attached.
Relevant disclosure is attached.
BSE9/1/2026
ESG Rating
The relevant disclosure is attached.
BSE8/24/2026
Earnings Call Transcript
Relevant disclosure attached
BSE8/11/2026
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Relevant disclosure attached
BSE8/11/2026material
Summary Of The Proceedings Of The 30Th Annual General Meeting.
The relevant disclosure is attached.
BSE8/11/2026material
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceeding of 30th Annual General Meeting
BSE8/11/2026material
Investor Presentation
The relevant disclosure is attached.
BSE8/6/2026
Board Meeting Intimation for Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30, 2026.
Fortis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve the Un-audited financial ....
BSE7/30/2026material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.